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Background: Endothelial-mesenchymal transition (EndoMT) has been shown to be a major source of myofibroblasts,
contributing to kidney fibrosis. However, in vitro study of endothelial cells often relies on culture of isolated primary
endothelial cells due to the unavailability of endothelial cell lines. Our recent study suggested that peritubular
endothelial cells could contribute to kidney fibrosis through EndoMT. Therefore, successful isolation and culture of
mouse peritubular endothelial cells could provide a new platform for studying kidney fibrosis. This study describes an
immunomagnetic separation method for the isolation of mouse renal peritubular endothelial cells using anti-CD146
MicroBeads, followed by co-culture with mouse renal proximal tubular epithelial cells to maintain endothelial
phenotype.
Results: Flow cytometry showed that after isolation and two days of culture, about 95% of cells were positive for
endothelial-specific marker CD146. The percentage of other cells, including dendritic cells (CD11c) and macrophages
(F4/80), was less than 1%. Maintenance of endothelial cell phenotype required vascular endothelial growth factor
(VEGF) and co-culture with mouse proximal tubular epithelial cells.
Conclusion: In this study, we established a method for the isolation of mouse renal peritubular endothelial cells by
using immunomagnetic separation with anti-CD146 MicroBeads, followed by co-culture with mouse renal proximal
tubular epithelial cells to maintain phenotype.
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Endothelial cells have been found to be a major source
of myofibroblasts via endothelial mesenchymal transition
(EndoMT), causing fibrosis in kidney and other organs
[1-4]. In one key study, Zeisberg and colleagues [4]
showed in three mouse models including unilateral ur-
eteral obstructive nephropathy (UUO), Alport disease and
streptozotocin-induced diabetic nephropathy, that around
30% to 50% of fibroblasts formed in the kidneys co-
expressed the endothelial marker CD31 and the fibroblast/
myofibroblast markers fibroblast specific protein-1 (FSP-1)
and/or α-smooth muscle actin (α-SMA). Endothelial
lineage tracing using Tie2-Cre;R26R-stop-EYFP transgenic
mice in the UUO model [4] and in streptozotocin-induced
diabetic nephropathy [5] further confirmed the presence* Correspondence: guoping.zheng@sydney.edu.au
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unless otherwise stated.of EndoMT-derived fibroblasts. However, elucidation of
molecular mechanisms of EndoMT involving glomerular
or peritubular endothelial cells relies largely on in vitro
studies using primary isolated human or mouse endothe-
lial cells. Such studies are limited by the loss of phenotype
that occurs in those primary endothelial cells in culture
after a limited number of passages.
Renal endothelial cells include glomerular endothelial
cells, peritubular endothelial cells and vascular endothe-
lial cells. Although it is generally accepted that endothe-
lial cells contribute to fibroblast formation in kidney, the
contribution of different renal endothelial cells has not
been defined. Previous studies examining EndoMT in
renal fibrosis were mostly focused on glomerular endothe-
lial cells, not surprisingly using the well-established
method for isolation of glomerular endothelial cells [6-9].
By immunofluorescence staining of kidney sections of
mice with UUO, co-localization of the mesenchymal
marker α-SMA and endothelial marker CD31 or VE-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Components of collagenase type IV solution
Collagenase D solution Volume or
concentration
Supplier
DMEM/F12 medium 7.5 ml Gibco Life Technologies;
Grand Island, NY, USA
Collagenase type IV 1 mg/ml Sigma Chemical Co.;
St Louis, MO, USA
Deoxyribonuclease 0.1 mg/ml Sigma Chemical Co.
Bovine serum albumin (BSA) 1 mg/ml Sigma Chemical Co.
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suggesting that the interstitial peritubular rather than
glomerular endothelial cells play the major role, at least in
the UUO model. To date, however, a method for isolation
of peritubular endothelial cells of high purity has not been
described [10]. For example, the method described by
Mcginn et al. [8] may isolate lymphatic and vascular
endothelial cells.
Primary endothelial cells are susceptible to phenotypic
change in culture; a co-culture system was, therefore,
developed to mimic the in vivo micro-environment in
the kidney with its key interactions between renal tubu-
lar epithelial cells and adjacent endothelial cells. Tasnim
et al. [10] described interactions by which human renal
glomerular endothelial cells improved the stability of the
human renal tubular cell phenotype while glomerular
endothelial cell phenotype was also well-maintained by
tubular epithelial cells. However, such a system may not
be applicable to the interaction between peritubular
endothelial cells and tubular epithelial cells in vivo.
Here we describe a method for isolation of primary
mouse renal peritubular endothelial cells (MRPEC) and
co-culture with mouse renal proximal tubular epithelial
cells. Our results show that separation with anti-CD146
MicroBeads resulted in peritubular endothelial cells of
high purity. Further, co-culture with mouse renal pro-
ximal tubular epithelial cells maintained the phenotype
of isolated peritubular endothelial cells, thus providing a
stable in vitro model for investigating the role of peri-
tubular endothelial cells in kidney diseases.
Methods
Animals
Male BALB/c mice (6 week old) were purchased from
Australian Research Council and experiments were
performed in accordance with protocols approved by
Animal Ethics Committee of Western Sydney Local
Health District.
Separation of tubular fraction from kidney cortex
Mouse kidney tubular fractions were obtained from the
kidney cortex of BALB/c mice using established methods
adapted from Doctor et al. [11]. Kidneys were perfused
in situ via the aorta with 20 ml phosphate buffered saline
(PBS; Lonza; Walkersville, MD, USA) containing 80U/ml
heparin to remove blood from anesthetized mice. Kidney
capsule was removed by peeling with forceps. Freshly iso-
lated kidneys were placed in ice-cold Dulbecco’s Modified
Eagle’s Medium mixed with Ham’s F12 (DMEM/F12; 1:1
ratio; Gibco Life Technologies; Grand Island, NY, USA)
on a petri dish. The kidney was sliced coronally and
homogenized by mincing into 1 mm3 to 2 mm3 pieces.
The homogenized kidney cortex tissue pieces were re-
suspended and mixed in 7.5 ml of collagenase type IVsolution (Table 1) and incubated at 37°C in a gentle shak-
ing water bath for 15 min. The suspension was homoge-
nized by pipetting 5 to 10 times through a sterile transfer
pipette followed by addition of 1 ml of fresh collagenase
type IV solution. This process was repeated 2-4 times.
About 40 ml fresh ice-cold DMEM/F12 was then added
into the collagenase digestion solution and the suspension
was centrifuged at 200 × g for 2 min. The pellet was resus-
pended and washed in 10 ml of fresh ice-cold DMEM/F12
and centrifuged at 150 × g for 2 min at 4°C. Density-
gradient centrifugation of the pellet was then performed
by resuspension in 25 ml of 45% (vol/vol) sterile Percoll
solution (Table 2) in 50 ml centrifugation tubes and
centrifugation at 5525 × g for 30 min at 4°C (without
braking). After centrifugation, the tubule fractions were
collected from the top layer of the Percoll solution (5 ml
of the top layer). The tubule fraction was washed once in
20 ml ice-cold DMEM/F12 medium at 300 × g for 5 min
at 4°C and resuspended for further experiments.
Isolation of proximal tubular epithelial cells from tubule
fraction
The pellet was resuspended in K1 medium [DMEM:
HAM’s F12; 1:1 vol/vol; Gibco Life Technologies) sup-
plemented with 25 μg/ml of epithelial growth factor
(EGF; Sigma Chemical Co.; St. Louis, MO, USA), 25 μM
HEPES (Invitrogen; Carlsbad, CA, USA), hormone mix-
ture (Table 3) and 5% fetal calf serum (FCS; Invitrogen)].
Proximal tubular epithelial cells were obtained by direct
culture after removing peritubular endothelial cells.
Isolation of peritubular endothelial cells from tubule
fraction
The tubule fractions were further digested with 0.025%
trypsin or collagenase type IV solution for 10 to 15 min
at 37°C to obtain single cell suspensions. After digestion,
ice-cold PBS was added to the cell suspension followed
by filtering sequentially through a 70-μm and a 40-μm
cell strainer. The filtered cell suspensions were then cen-
trifuged at 300 × g for 2 min at 4°C. The pellet was re-
suspended in MicroBeads resuspension buffer [prepared
in PBS, containing 0.5% BSA (Sigma Chemical Co.) and
2 mM EDTA (Life Technologies)] and centrifuged again
at 300 × g for 3 min at 4°C. The cell pellets obtained
Table 2 Percoll solution (25 ml)
Percoll solution Volume Supplier
DMEM/F12 medium 12.5 ml Gibco Life Technologies;
Grand Island, NY, USA
Percoll (45%, vol./vol.) 11.25 ml Gibco Life Technologies
20 X concentrated PBS 0.5625 ml AMRESCO; Solon, OH, USA
MilliQ water 0.5625 ml Roche Applied Science;
Penzberg, Upper Bavaria, Germany
1 M HEPES 80.5 μl Gibco Life Technologies
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resuspension buffer and incubated with anti-mouse
CD16/32 antibody (Fc-blocking) for 15 min to block
non-specific binding. The cell pellets were then magne-
tically labeled with CD146 (LSEC) MicroBeads (MACS;
Miltenyi Biotechnology; Bergisch Gladbach, Germany)
and separated according to the manufacturer’s instruc-
tions. Specifically, cells were incubated with CD146
MicroBeads and then passed through a magnetic field.
Peritubular cells were collected and cultured in the pre-
warmed endothelial cell medium (ScienCell; Carlsbad,
CA, USA) in fibronectin (Sigma Aldrich) pre-coated
Transwell plates. Purity of the isolated peritubular en-
dothelial cells was determined by immunofluorescent
staining and flow cytometric analysis. Before FACS stai-
ning, the beads were detached from the cells using the
MultiSort Release Reagent (MACS), which enzymatically
removes the MicroBeads [Additional file 1].
Flow cytometry analysis (FACS)
Adherent endothelial cells were detached from culture
flasks with trypsin/EDTA (Life Technologies), washed and
resuspended in PBS (Gibco Life Technologies) containing
1% FCS. Cells (106 cells/ml) were then incubated with re-
spective FITC-, PE- or APC-conjugated monoclonal anti-
bodies for 20 min at 4°C. Fluorescence antibody-labeledTable 3 Components of hormone mixture in K1 medium
Ingredient Supplier Stock so
Insulin Sigma Chemical Co., St. Louis, MO, USA Powder
Prostaglandin E1 Cayman Chemical, Ann Arbor, MI, USA 0.5 mg/m
3,3,5-triiodothyro–nine Sigma Chemical Co. 16.9 mg/
Transferrin Sigma Chemical Co. Powder
Sodium selenite Sigma Chemical Co. 0.173 mg
Hydrocortisone Sigma 0.18 mg/
The hormone mixture was brought to a final volume of 100 ml with HBSS/HEPES, a
*HBSS/HEPES = Hanks Balanced Salt Solution without calcium and without magnesicells were then washed twice in cold PBS with 1% FCS
and analyzed using a flow cytometer (BD Bioscience;
San Jose, CA, USA).
Antibodies
Antibodies for flow cytometry were as follows: anti-mouse
F4/80 antigen Alexa Fluor® 488, anti-mouse Lyve-1 Alexa
Fluor® 488, anti-mouse CD31 (PECAM-1) APC, anti-
mouse CD45 PE, anti-mouse CD11c Alexa Fluor® 488
(eBioscience; San Diego, CA, USA), PE-anti-mouse CD146,
Alexa Fluor® 488 anti-mouse panendothelial cell antigen
(Biolegend; San Diego, CA, USA), FITC-anti-mouse FSP-1/
S100A4 (LifeSpan BioSciences; Seattle, WA, USA) and
anti-mouse PDGFR-β Alexa Fluor® 488 (BD Bioscience).
For isotype antibody controls, rat IgG2a κ Alexa Fluor®
488 (eBioscience) was used for F4/80, rat IgG1 κ Alexa
Fluor® 488 (eBioscience) was used for Lyve-1, FSP-1 and
PDGFR-β, rat IgG2a κ APC (eBioscience) was used for
CD31, rat IgG2a κ PE (eBioscience) was used for CD45,
Armenian hamster IgG Alexa Fluor® 488 (eBioscience)
was used for CD11c, and PE rat IgG2a, κ (Biolegend)
was used for CD146, and Alexa Fluor® 488 rat IgG2a, κ
(Biolegend) was used for PV-1.
Primary antibodies for immunofluorescence were as fol-
lows: rabbit polyclonal anti-VE-cadherin (1:200; Alexis
Biochemicals; Farmingdale, NY, USA), rabbit polyclonal
anti-FSP-1/S100A4 (1:400; Merck Millipore; Billerica, MA,
USA), rat monoclonal anti-CD11c (1:200; eBioscience), rat
monoclonal anti-F4/80 (1:200; eBioscience), purified rat
anti-CD73 (1:50; BD Bioscience), rabbit monoclonal anti-
PDGFR-β (Abcam; Cambridge, UK), and mouse mo-
noclonal anti-actin, α-smooth muscle (Sigma Chemical
Co.). For isotype antibody controls, rat IgG2a κ Purified
(eBioscience) was used for VE-cadherin and F4/80, rab-
bit IgG (Invitrogen) was used for FSP-1 and PDGFR-β,
Armenian hamster IgG purified (eBioscience) was used for
CD11c, Purified Mouse IgG1, κ (BD Bioscience) was used
for CD73, and mouse IgG2a, κ (Biolegend) was used for
α-SMA.lution Vol./wt. of addition
50 mg dissolved in 10 ml of HBSS/HEPES*
and small amount of NaOH
l (in EtOH) 25 μl
ml (0.026 M) (in EtOH) 2 μl of stock added to 10 ml HBSS/HEPES*
then used in 100 μl aliquots
50 mg
/ml (10-6 M) in HBSS/HEPES 100 μl
ml (in EtOH) 1 ml
nd aliquoted into 5 ml or 10 ml portions and stored at –80°C.
um (Gibco, Life Technologies; Grand Island, NY, USA)/1% HEPES.
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follows: fluorescent-conjugated secondary anti-rabbit Alexa
Fluor® 488 (1:600; Invitrogen), anti-mouse Alexa Fluor® 546
(1:600; Invitrogen) and anti-rat Alexa Fluor® 488 (1:600;
Invitrogen).Cell culture
The primary mouse peritubular endothelial cells isolated
using MicroBeads were cultured in endothelial cell
medium containing VEGF (Sigma-Aldrich; St. Louis,
MO, USA) (2.5 μg/ml to 5 μg/ml) according to a pre-
viously described method [6]. The endothelial cell
medium contained 93% of basal medium (ScienCell), 5%
fetal bovine serum (FBS; ScienCell), 1% endothelial cell
growth supplement (ECGS; ScienCell) and 1% penicillin/
streptomycin (P/S; ScienCell). Cells were maintained at
37°C in 5% CO2 and incubated overnight in plates pre-
coated with fibronectin in endothelial cell medium, non-
adherent cells were removed and medium was changed.
Then medium was changed every 2-3 days. Experiments
with mono-cultures and co-cultures were performed in fi-
bronectin precoated 6-well Transwell plates (BD Bioscience)
with polyester inserts (pore size 0.4 μm) with endothelial
cell medium. The proximal tubular epithelial cells from
tubule fractions were incubated overnight in plates in K1
medium at 37°C with 5% CO2, non-adherent cells were re-
moved and medium was changed. Then medium was
changed every 2-3 days. In the co-culture system, peritu-
bular endothelial cells were placed in the bottom chamber
of Transwell plates while proximal tubular epithelial cells
were placed in polyester inserts and cultured in endothe-
lial cell medium.Immunofluorescence
For immunofluorescent staining, cells were seeded on
glass coverslips in 6-well culture plates and cultured until
they reached 50% to 60% confluence. Cells were then
washed with PBS, fixed with absolute methanol for 10 min
at -20°C, and blocked with 2% BSA (Sigma Chemical Co.)
for 1 h at room temperature. The coverslips were incu-
bated for 1 h at room temperature with primary antibodies
against endothelial cell marker VE-cadherin, fibroblast cell
marker FSP-1, dendritic cell marker CD11c, macrophage
cell marker F4/80, perivascular fibroblast marker CD73, or
pericyte specific marker PDGFR-β. After washing in PBS
and distilled water, cells were incubated with fluorescent-
conjugated secondary antibody for 40 min at room tem-
perature in the dark. The coverslips were then washed in
PBS and distilled water and counterstained with 4′,6-dia-
midino-2-phenylindole (DAPI) (Invitrogen) for 5 min.
After washing in PBS and distilled water, the cover-
slips were mounted with fluorescence mounting medium
(Dako; Glostrup, Denmark) and subjected to fluorescencemicroscopy. Isotype controls of corresponding secondary
antibodies were used as negative controls.
Semiquantitative assessment of immunofluorescent
staining
A minimum of 10 consecutive fields of immunofluo-
rescent images were taken from each slide of stained
MRPECs with total cell count of at least 2000 cells. Re-
sults were obtained from duplicate slides of a minimum
three independent experiments. The number of positive
staining cells was counted according to the number of
nuclei counterstained by DAPI (blue).
Statistical analysis
Results from at least three independent experiments were
expressed as mean ± SEM. Statistical significance was
evaluated using a two-tail t-test for comparison between
two groups. A value of P < 0.05 was considered statistically
significant.
Results
Anti-CD146 MicroBeads isolation of peritubular
endothelial cells from the tubule fraction of kidney cortex
Following isolation using anti-CD146 MicroBeads, the
peritubular endothelial cells were assessed by FACS ana-
lysis. The FACS results show that before magnetic se-
paration, the percentage of CD146-positive cells was
around 8% (Figure 1A, left panel). The percentage of
CD146-positive cells was around 38% after magnetic
separation (Figure 1A, middle panel). To improve purity,
we used Fc-blocking and typsinisation. Fc-blocking was
used in our isolation of peritubular endothelial cells with
anti-CD146 (rat anti-mouse) MicroBeads as described
[12] to avoid non-specific binding. To obtain single-cell
suspensions from MicroBeads isolation, the tubule frac-
tion underwent digestion with optimized concentrations
of trypsin to avoid co-sorting of non-endothelial cells by
sorting of endothelial-non-endothelial cell aggregates.
The FACS results showed that Fc-blocking and trypsin
digestion increased the percentage of CD146 positive
endothelial cells from 39% (Figure 1A, middle panel) to
45% (Figure 1A, right panel).
MicroBeads concentration optimization and kidney
perfusion to increase purity of isolated peritubular
endothelial cells
After MicroBeads (1:20) isolation, 15% of cells were
CD45+ (Figure 1B, middle panel), suggesting contami-
nation with blood cells. Therefore, we performed kidney
perfusion before digestion to remove blood cell. The
peritubular endothelial cell purity thus was increased
to 70% and CD45 positive cells reduced to around 1%
(Figure 1B, right panel). To further improve the purity,
the MicroBeads to cell suspension ratio was optimized.
Figure 1 (See legend on next page.)
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Figure 1 Flow cytometric analysis of peritubular endothelial cells isolated by MicroBeads. (A) Flow cytometry analysis of CD146-PE positive
endothelial cells before (left panel), after MicroBeads isolation (middle panel), and after MicroBeads isolation with Fc-blocking and trypsin digestion
(right panel). Shaded areas are respective isotype controls. (B) Flow cytometry analysis of blood cell (CD45) contamination when CD146-PE positive
endothelial cells were isolated with MicroBeads (1:20) with (right panel) or without kidney perfusion (left panel). Shaded areas are respective isotype
controls. (C) After perfusion, CD146-PE positive cells before (top left panel) and after MicroBeads isolation at different MicroBeads concentration:
1:5 (top middle panel), 1:20 (top right panel), 1:30 (bottom left panel) and 1:50 (bottom right panel). Shaded areas are respective isotype controls.
(G) Statistical analysis of each individual experiment (N = 3). After modification of kidney perfusion and optimization of MicroBeads concentration, the
purity of CD146 positive cells increased significantly from 7.5 ± 0.3 (before separation) to as high as 83.3 ± 1.7. Data are expressed as mean ± SEM with
N = 3 for each experimental group. *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 2 Assessments of purity of cultured endothelial cells.
(A) Flow cytometry analysis of CD11c, Lyve-1, CD45, F4/80, FSP-1 and
PDGFR-β positive cells in MicroBeads isolated peritubular endothelial
cells after 2 days of culture. Shaded areas are respective isotype
controls. (B) Flow cytometry analysis of the MicroBeads isolated
peritubular endothelial cells by CD146, CD31 and PV-1 after 2 days of
culture with statistical analysis (N = 3 independent experiments)
(bottom panel).
Zhao et al. BMC Cell Biology 2014, 15:40 Page 6 of 10
http://www.biomedcentral.com/1471-2121/15/40After kidney perfusion, when MicroBeads to cell suspen-
sion ratio was changed from 1:5 to 1:30 (Figure 1C, top
panels), the purity of CD146 positive endothelial cells
was increased to >80% (Figure 1C, bottom left panel)
while the purity by further dilution at a ratio of 1:50
remained at the same level (Figure 1C, bottom right
panel). So the final ratio of MicroBeads to cell suspen-
sion used was 1:30.
2 days of culture after MicroBeads isolation to increase
purity of peritubular endothelial cell
After incubation with the optimal concentration of
MicroBeads (1:30) and following immunomagnetic separ-
ation, the percentage of CD146-positive cells remained
stable at about 80%. Magnetically isolated peritubular endo-
thelial cells were cultured for two days and then analyzed
with antibodies for different cell surface markers to deter-
mine the purity of endothelial cells and possible contami-
nation of other cells by FACS. The peritubular endothelial
cells were incubated with antibodies for lymphatic ves-
sel endothelial cell marker Lyve-1, dendritic cell marker
CD11c, hematopoietic cell marker CD45, macrophage cell
marker F4/80, fibroblast cell marker FSP-1, pericyte cell
marker PDFGR-β, and endothelial cell markers CD146 and
CD31. To distinguish from glomerular endothelial cells,
PV-1 was used as peritubular endothelial marker [13]. The
FACS results showed that the respective percentage for
other cell type was less than 1.83% (Figure 2A). The per-
centage of CD31 positive cells was 78% and that of CD146
positive cells was 92% (Figure 2B). These results could be
due to CD31 being trypsin sensitive [12] while CD146 is
trypsin resistant. However, the percentage of contaminating
cells could potentially be higher if their surface markers
were trypsin sensitive. The results after 2 days culture sug-
gested that culturing of isolated peritubular endothelial cells
further improved their purity, possibly through separation
of adherent endothelial cells from other non-adherent cells.
Over 2 million cells were obtained from each mouse.
Immunofluorescence staining to show high purity of
isolated mouse renal peritubular endothelial cells
(MRPECs)
The high purity of isolated MRPECs shown by FACS
analysis was further confirmed with immunofluorescentstaining. After two days of culture, immunofluorescent
staining of isolated MRPECs showed that all cells were
VE-cadherin positive and few cells were FSP-1 positive
(Figure 3A, B). Immunofluorescent staining for CD11c
and F4/80 also suggested that no dendritic or macro-
phage cells were present (Figure 3C, E). To confirm the
absence of pericyte contamination, cells were stained for
CD73 and PDGFR-β. Results showed that almost none
Figure 3 Immunofluorescence staining assessment of
MicroBeads isolated peritubular endothelial cells after 2 days
culture. Immunofluorescence staining of isolated peritubular
endothelial cells against VE-cadherin (green, A), FSP-1 (green, indicated
by white arrow, B), CD11c (green, C), F4/80 (green, E), and positive
control for CD11c (primary spleen dendritic cells, green, D) and F4/80
(primary spleen macrophage, green, F), Immunofluorescence staining
against pericyte marker CD73 (green, G) and PDGFR-β (green, I), and
positive control for CD73 (frozen kidney sections of BALB/c mouse,
green, H) and PDGFR-β (frozen kidney sections of BALB/c mouse, green,
J). (K) Statistical analysis of each individual marker immunofluorescent
stained and quantified as a percentage of positively stained cells against
total cells (2000). Data are expressed as mean ± SEM with N = 10 for
each experimental group. Original magnification was x 200; original
magnification for pericytes staining was x 400. Cells in this figure were
counterstained with DAPI to visualize nuclei (blue).
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Therefore, taken together the FACS analysis and immuno-
fluorescent results showed that MRPECs of high purity
were successfully isolated from mouse renal tissue.Co-culture with proximal tubular epithelial cells and VEGF
to prevent phenotypic change of isolated peritubular
endothelial cells
Immunofluorescence staining of MRPECs cultured for 2,
4 and 6 days showed VE-cadherin positive staining. How-
ever, a large number of cells were also α-SMA positive
after 2 days of culture, suggesting that the cells were
undergoing phenotypic change (Figure 4A). To main-
tain MRPEC endothelial phenotype, vascular endothelial
growth factor (VEGF) was added to the culture medium
and MRPECs were co-cultured with mouse proximal
tubular epithelial cells (MPTECs) which were obtained via
direct culture of tubule fractions (Figure 4B). FSP-1 and
α-SMA were used as markers for fibroblasts [4]. While
FSP-1 (Figure 4C, top panels) staining was low in all
groups, α-SMA staining co-localized with VE-cadherin
(Figure 4C, bottom panels) significantly diminished in cul-
ture of peritubular endothelial cells after treatment with
VEGF and especially when combined in co-culture with
proximal tubular epithelial cells (Figure 4C, D). Statistical
analysis showed the effect of co-culture of MRPECs with
MPTECs was minimal as compared to mono-culture of
MRPECs without any treatment (Figure 4D). However,
α-SMA expression decreased significantly when the cells
were treated with VEGF (from 35.0 ± 3.6 to 14.3 ± 3.0,
P <0.05). When the cells were co-cultured with MPTECs
and treated with VEGF, the number of α-SMA positive
cells was the lowest among all groups (from 35.0 ± 3.6 to
5.3 ± 1.5, P < 0.001) (Figure 4D). This result demonstrated
that co-culture with MPTECs and VEGF treatment is an
effective method for maintaining isolated MRPECs.
Figure 4 (See legend on next page.)
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Figure 4 Primary mouse renal peritubular endothelial cell performance in mono- and co-culture with mouse proximal tubular epithelial cell
over 6 days. (A) Co-localization of VE-cadherin (green) and α-SMA (red) positive cells cultured in MPRECs mono-cultures without VEGF. (B) Peritubular
endothelial cell and proximal tubular epithelial cell co-culture. In the co-culture system, isolated peritubular endothelial cells were placed in the bottom
chamber of fibronectin pre-coated Transwell plates and proximal tubular epithelial cells were seeded onto the polyester inserts (pore size 0.4 μm).
Endothelial cell medium was used for the co-culture. (C) After 6 days, primary mouse renal peritubular endothelial cell performance in mono- and
co-culture in the presence or absence of VEGF was assessed by FSP-1(green, top panels) staining and co-localization of α-SMA (red) and VE-cadherin
(green, bottom panels). Orange represents α-SMA and VE-cadherin double positive areas. (D) Statistical analysis of primary mouse renal peritubular
endothelial cell performance after cells were cultured for 6 days. FSP-1 (green) and α-SMA (red) expression in MRPECs was quantified and expressed as
a percentage of positive stained cells against total cells. Images presented are representative of at least 5 independent replicate experiments. Data are
expressed as mean ± SEM with N = 5 for each group. *P< 0.05, **P< 0.01 vs. respective control. Original magnification was x 200. Cells in this figure
were counterstained with DAPI to visualize nuclei (blue).
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Anti-CD146-conjugated MicroBeads have been used for
isolation of endothelial cells from liver [14]. Anti-CD31
was previously used in isolation of endothelial cells.
However, pericytes are also positive for CD31. In ad-
dition, endothelial surface expression of CD31 could be
decreased by trypsin digestion during isolation as de-
monstrated in our current study. Therefore, we used for
the first time anti-CD146 MicroBeads to isolate peri-
tubular endothelial cells. Our results showed that the
percentage of CD146-positive cells was as high as 92%
while that of CD31-positive cells was up to 80%. To se-
parate peritubular endothelial cells from pericytes, which
may also be positive for CD146, we isolated peritubular
cells using an established method for high-purity tubules
isolation [15] to avoid pericyte contamination. Isolated
peritubular endothelial cells stained negatively for the
pericyte markers CD73 and PDGFR-β [16], while they
were positive for VE-cadherin.
To improve the purity of cells isolated from tubular
fractions with trypsin-EDTA digestion, treatment of the
suspensions with Fc-blocking reagents (mouse Ig) is
needed to avoid contamination with the other types of
cells that express Fc receptor. Marelli-Berg et al. [12]
showed that treatment with Fc-blocking reagents is es-
sential for high specificity and efficiency during positive
selection, particularly when using antibodies derived
from a closely related species (e.g. rat anti-mouse).
Enzymatic digestion, particularly with trypsin-EDTA,
has been reported by Marelli-Berg and colleagues to be
capable of lowering surface level of CD31 [12]. They
showed that much higher levels of CD31 could be de-
tected on endothelial cells as compared to those endothe-
lial cells after treatment with trypsin–EDTA solution to
detach them from the culture flasks. This may account for
the difference between CD31 and CD146 staining (80% vs.
92%) for isolated peritubular endothelial cells. However,
trypsin treatment is necessary for preparation of single cell
suspensions. In addition, we optimized the trypsin con-
centration to minimize the influence on other cell surface
markers.Renal peritubular endothelial cells are, however, sus-
ceptible to undergoing phenotypic change in culture.
Manual removal of phenotype-changed cells [8] is
technically difficult to optimize. A co-culture system
was, therefore, developed to mimic the in vivo micro-
environment of the kidney in which the interactions
between renal tubular epithelial cells and adjacent endo-
thelial cells are vital for survival of peritubular endo-
thelial cells [10]. VEGF was used previously to aid
maintenance of endothelial cell phenotype [6]. Our re-
sults proved that VEGF can help MRPECs maintain
their phenotype, possibly because VEGF has profound
effects on endothelial cells and stimulates their survival
and proliferation, as well as vasculogenesis and angio-
genesis [17,18]. Furthermore, co-culture with proximal
tubular epithelial cells increased the stability of the
endothelial phenotype beyond that achieved by incuba-
tion with VEGF alone. It is possible that renal epithelial
cells and endothelial cells formed a micro-environment
that positively affects both cell types and promotes sur-
vival and proliferation.
The potentially critical interactions between epithelial
and endothelial cells and soluble factors in the micro-
environment have been described in a study by Tasnim
and Zink [10]. They showed that co-culture with proxi-
mal tubular epithelial cells stimulated glomerular endo-
thelial cells to express increased amounts of hepatocyte
growth factor (HGF) and VEGF. In addition, endothelial
cells also secreted increased amounts of TGF-β1 and its
antagonist α2-macroglobulin (A2M) in the presence of
proximal tubular epithelial cells. A2M balanced the ef-
fects of TGF-β1 and the long-term maintenance of renal
epithelia was improved in the presence of HGF and
VEGF [19,20]. Here we described a co-culture of tubular
epithelial cells with peritubular endothelial cells. Al-
though the mechanism remains to be explored, peritub-
ular rather than glomerular endothelial cells are the
endothelial cells that interact with tubular epithelial cells
in vivo in kidney. Thus, the co-culture system better re-
flects the physiological environment of peritubular endo-
thelial cells.
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We have successfully isolated peritubular endothelial cells
from mouse renal tissue with high purity and maintained
their phenotype in a co-culture system. The methods of
peritubular endothelial cell isolation and co-culture estab-
lished in this study should provide an in vitro model for
investigation the role of peritubular endothelial cells in
kidney fibrosis and all other tubulointerstitial kidney
diseases.
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